Hypertrophic cardiomyopathy: New hope for an old disease

Gail Larkin1, Tamara Bellomo, Lenel Caze

  • 1Gail Larkin and Lenel Caze are assistant professors in the Paramedic Program within the Nursing Department at Kingsborough Community College in Brooklyn, NY. Tamara Bellomo is an associate professor in the Nursing Program in the Nursing Department, also at Kingsborough Community College.

Nursing
|August 1, 2019
PubMed

Insights

Hypertrophic cardiomyopathy (HCM) is a common congenital heart disease leading to sudden cardiac death in young people. While older adults with HCM face fewer sudden deaths, their quality of life may suffer, necessitating specific care strategies.

Area of Science:

  • Cardiology
  • Genetics
  • Internal Medicine

Background:

  • Hypertrophic cardiomyopathy (HCM) is a prevalent genetic heart condition.
  • It is the primary cause of sudden cardiac death in young individuals, including athletes.
  • While less common in older adults, HCM significantly impacts their quality of life.

Purpose of the Study:

  • To outline current diagnostic criteria for hypertrophic cardiomyopathy in adults.
  • To review established and emerging treatment options for HCM.
  • To detail essential nursing interventions and patient education strategies for adults with HCM.

Main Methods:

  • Review of current medical literature and clinical guidelines.
  • Analysis of diagnostic approaches for HCM.
  • Synthesis of treatment modalities and nursing care principles.

Main Results:

  • Diagnostic criteria for HCM involve clinical, imaging, and genetic assessments.
  • Treatment strategies range from medication to surgical interventions and device therapy.
  • Nursing care focuses on symptom management, medication adherence, and lifestyle modifications.

Conclusions:

  • Early diagnosis and comprehensive management are crucial for improving outcomes in adults with HCM.
  • Tailored nursing interventions, including patient education, enhance quality of life and reduce complications.
  • Ongoing research aims to refine treatment protocols and personalize care for HCM patients.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
426
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
490
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
486
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
520
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
320
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
357